Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
507.00    -2.00 (-0.39%)
Bid:
508.00
Ask:
509.00
Spread: 1.00 (0.197%)
Market Cap: £497.89m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

New Incentive Plan

12 Oct 2016 11:00

RNS Number : 1120M
Galliford Try PLC
12 October 2016
 

Galliford Try plc

(the "Company")

 

Proposed performance conditions for first awards under new Long Term Incentive Plan (the "Plan")

 

The Company intends to make its first awards under a new long-term incentive plan shortly following and contingent on shareholder approval at the 2016 Annual General Meeting for the new Plan.

 

The Company can now confirm that the performance conditions proposed for such first awards will be structured as previous grants and comprise measures of earnings per share ("EPS") and total shareholder return ("TSR") in respect of a performance period comprising three consecutive financial years of the Company starting with the current year ending 30 June 2017.

 

The vesting of up to 50% of each base award will be based on EPS performance, 15% of the base award will vest for aggregate EPS of 489 pence over the performance period, increasing to 50% of each base award vesting for aggregate EPS of 568 pence.

 

7.5% of each base award will vest for the Company's TSR performance against a Housebuilding Comparator Group ranking equal to median performance, increasing to 25% vesting of each base award if the Company's TSR is 24% higher than that of the median ranked company in such comparator group.

 

Vesting for relative TSR performance against the Housebuilding Comparator Group can increase to a maximum of 75% of each base award for the Company achieving a TSR that is 75% higher than the median ranked comparator company. Any vesting above 25% of each base award in relation to such TSR however also requires the maximum EPS target noted above to have been achieved.

 

The vesting of up to 75% of each base award will be based on the Company's TSR performance over the performance period relative to the TSRs over the same period of the companies within a Construction Comparator Group. Vesting under such measure will be calculated on the same basis as described above in relation to the Housebuilding Comparator Group but by reference to the Construction Comparator Group.

 

In aggregate 200% of each base award may vest subject to the terms and conditions of the Plan.

 

Housebuilding Comparator Group:

 

Barratt Developments plc, Bellway plc, Bovis Homes Group plc, Countryside plc, Crest Nicholson Holdings plc, McCarthy & Stone plc, M J Gleeson Group plc, Persimmon plc, Redrow plc, Taylor Wimpey plc and The Berkeley Group Holdings plc.

 

Construction Comparator Group:

 

Balfour Beatty plc, Carillion plc, Kier Group plc, Morgan Sindall Group plc, Costain Group plc, Keller Group plc and Henry Boot plc.

 

For further enquiries:

 

Galliford Try plc

Kevin Corbett, Company Secretary

01895 855001

Clara Melia, Investor Relations

07748 171 236

Tulchan Communications

James Macey White

0207 353 4200

Martin Pengelley

Matt Low

 

 

 

Galliford Try plc is a leading UK housebuilding and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes and Galliford Try Partnerships and Regeneration businesses - sells distinctive homes to the public and affordable homes to housing associations and local authority providers. The construction business carries out building and infrastructure work across the UK with clients ranging from major Government departments through to regulated utilities and private sector companies. At the end of the last financial year to 30 June 2016, the Group generated revenues of £2.5 billion.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKBLBFQBFXFBB
Date   Source Headline
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20224:00 pmRNSAnnual Financial Report
7th Oct 20224:00 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTotal Voting Rights
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20225:30 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20225:03 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20224:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20223:00 pmRNSEmployee Share Trust Trading Plan
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:01 amRNSLaunch of Share Buyback Programme
21st Sep 20227:00 amRNSFinal Results
1st Aug 20227:00 amRNSContract
14th Jul 20227:00 amRNSTrading Statement
11th Jul 20227:00 amRNSAcquisition of MCS Control Systems
1st Jul 202211:00 amRNSDirector Declaration
23rd Jun 20227:00 amRNSContract
31st May 20227:00 amRNSTotal Voting Rights
30th May 202210:00 amRNSExercise of share options
10th May 20227:00 amRNSBusiness Briefing
26th Apr 20227:00 amRNSAppointment of Director
1st Apr 20229:10 amRNSConfirmation of Directorate Change
15th Mar 20227:00 amRNSDirectorate Change
4th Mar 20225:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSHalf-year Results
9th Feb 20227:00 amRNSContract
19th Jan 20227:00 amRNSTrading Update
31st Dec 202112:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 202111:51 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSContract
12th Nov 20214:01 pmRNSResult of AGM
12th Nov 20217:00 amRNSAGM Statement
7th Oct 20213:23 pmRNSAcquisition
7th Oct 202110:27 amRNSDirector Declaration
6th Oct 20217:00 amRNSContract
5th Oct 20214:47 pmRNSAnnual Financial Report
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20214:00 pmRNSDirector/PDMR Shareholding
17th Sep 20211:00 pmRNSEmployee Share Trust Trading Plan
16th Sep 20217:00 amRNSFinal Results
26th Aug 20213:42 pmRNSHolding(s) in Company
16th Aug 202110:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.